Faeth: PIKTOR pivotal trial design expected 1H 2027 after Phase 2 endometrial dataNov 13Clinical readoutAbvc Biopharma, Inc.Actuate Therapeutics Inc.Updated
ABVC Biopharma raises $3.39 million through convertible note private placementNov 10FinancingAbvc Biopharma, Inc.
ABVC BioPharma closes $3.39 million convertible note private placementNov 2FinancingAbvc Biopharma, Inc.
ABVC BioPharma flags going-concern doubt in 10-Q, delays BioKey Cayman spinoffAug 17FinancingAbvc Biopharma, Inc.